<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02588417</url>
  </required_header>
  <id_info>
    <org_study_id>no id</org_study_id>
    <nct_id>NCT02588417</nct_id>
  </id_info>
  <brief_title>Intrathecal Dexamethasone and Labor Analgesia</brief_title>
  <official_title>Intrathecal Levobupivacaine Versus A Combination of Levobupivacaine and Dexamethasone in Parturients Receiving Combined Spinal Epidural for Vaginal Delivery Analgesia: A Comparative Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ahmed elsakka</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effectiveness of adding dexamethasone to intrathecal levobupivacaine in
      combined spinal epidural (CSE) analgesia during vaginal delivery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective double-blind trial included 80 primigravidas during vaginal delivery with a
      cervical dilatation ≥ 4 cm and 50% effacement randomly assigned to one of two equal groups;
      Group L received intrathecal levobupivacaine 0.25% in 2 mL and Group LD received intrathecal
      levobupivacaine 0.25% combined with dexamethasone 4 mg in 2 mL. At first request of
      analgesia, a combination of 0.25% levobupivacaine with 100 μg fentanyl in 10 ml via the
      epidural catheter. Further analgesia was provided with 7 ml 0.25% levobupivacaine hourly. The
      primary outcome measure was the duration of spinal analgesia. Secondary outcome measures
      include time from spinal analgesia to delivery, total amount of epidurally administered
      levobupivicaine, adverse effects of neuraxial block and neonatal outcome.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>duration of spinal analgesia</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>time from spinal analgesia to delivery</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Effects of; Anesthesia, in Labor and Delivery</condition>
  <arm_group>
    <arm_group_label>dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dexamethasone 4 mg administered intrathecally during active stage of labor once only in combination with levobupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>levobupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>levobupivacaine 2.5 mg in 2 ml administered intrathecally during active stage of labor once and alone and then epidural levobupivacaine 7ml of 2.5 mg concentrationis administered till the end of labor</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>4mg dexamethasone intrathecally plus levobupivacaine 2.5 mg</description>
    <arm_group_label>dexamethasone</arm_group_label>
    <other_name>decadron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine</intervention_name>
    <description>levobupivacaine 2.5 mg</description>
    <arm_group_label>dexamethasone</arm_group_label>
    <arm_group_label>levobupivacaine</arm_group_label>
    <other_name>chirocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA physical status I,II patients schedueled for normal vaginal deliveries

          -  age between 18-35 years old

        Exclusion Criteria:

          -  Patients who refused to participate

          -  complicated pregnancies
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>nadia yo helmy, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>professor of anaesthesia cairo university</affiliation>
  </overall_official>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2015</study_first_submitted>
  <study_first_submitted_qc>October 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2015</study_first_posted>
  <last_update_submitted>October 27, 2015</last_update_submitted>
  <last_update_submitted_qc>October 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>ahmed elsakka</investigator_full_name>
    <investigator_title>dr</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

